Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesTransplantEmblemHealth transplant device coverage update | O…
    Ask Trek AI about this page

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    CurrentEmblemHealthPolicy N/A

    Medical technologies and investigational transplant-related devices/services

    Customize your policy alerts

    Sign up for all EmblemHealth policy alerts

    Know when EmblemHealth releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Lists investigational, investigational-with-exceptions, and coverage notes for medical devices and technologies relevant to transplant program case management and other services; applies to EmblemHealth members and providers requesting review or pre-certification.

    Policy Summary
    PayerEmblemHealth
    PolicyMedical technologies and investigational transplant-related devices/services
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateN/A
    Last ReviewApr 10, 2026
    Next Review DateN/A
    Key ActionSubmit pre-certification requests for listed devices and transplant services for case-by-case review and include supporting documentation for indications (e.g., epilepsy or Medicare TRD when applicable).
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    multipleinvestigational entries
    case managementtransplant support
    investigationalVNS stance
    Epilepsy/TRDVNS exceptions
    HDE referencedHDE note

    Coverage Determinations and Policy Statements

    Scalp cooling coverage

    Scalp cooling for chemotherapy-related hair loss

    Scalp cooling for chemotherapy: EmblemHealth considers scalp cooling medically necessary to prevent hair loss during chemotherapy; cooling caps and other scalp cooling products are considered incidental to chemotherapy administration and are not separately reimbursed; items purchased by the member may be excluded under plans that exclude supplies.

    CPT 0662T, 0663T cited

    AbioCor® coverage handling

    AbioCor® Implantable Replacement Heart (HDE)

    AbioCor HDE handling: AbioCor® is FDA-approved as a Humanitarian Device Exemption (HDE) for select patients with severe biventricular end‑stage heart disease who are not cardiac transplant candidates; pre-certification requests will be reviewed on a case‑by‑case basis for all lines of business except Medicare, where CMS National Coverage Determination (NCD) provisions apply for qualifying clinical study enrollment.

    CPT 33927, 33928, 33929, L8698

    Reclaim™ DBS coverage handling

    Reclaim™ DBS Therapy

    Reclaim DBS: Reclaim™ DBS is FDA‑approved under a Humanitarian Device Exemption (HDE) for bilateral stimulation of the anterior limb of the internal capsule as an adjunct to medications for treatment‑resistant obsessive‑compulsive disorder (OCD) in adults who have failed at least three SSRIs; pre‑certification requests will be reviewed on a case‑by‑case basis.

    CPT codes listed in database rows (e.g., 21499, 61863–61888, 95961–95962)

    Vagus Nerve Stimulation

    Coverage stance is indicated per technology:

    Vagus nerve stimulation coverage: Vagus nerve stimulation is considered investigational for all indications except epilepsy and treatment‑resistant depression (TRD) for Medicare members under the National Coverage Determination via Coverage with Evidence Development (CED); prior authorization is required for listed VNS CPT codes and documentation must demonstrate the approved indication (see MCG #A‑0424 for epilepsy and Medicare NCD for TRD CED).

    CPT 0312T–0317T, 61885, 61886, 61888; see MCG #A‑0424 and Medicare NCD

    Venoplasty for Multiple Sclerosis

    Venoplasty for relapsing remitting MS: Venoplasty for relapsing remitting multiple sclerosis is listed as investigational and is not considered established therapy.

    CPT 36901–36906 listed

    Cooling caps and other scalp cooling products are considered incidental to chemotherapy administration and are not separately reimbursed. Items purchased by the member (for example, scalp cooling caps) may be treated as excluded supplies under plans that exclude supplies. Relevant CPT codes: 0662T, 0663T.

    Requests for vagus nerve stimulation (VNS) for indications listed as investigational are considered investigational and may be denied. VNS is considered investigational for most indications except for epilepsy (see MCG #A-0424) and treatment‑resistant depression (TRD) for Medicare members under the NCD CED pathway. Examples of investigational indications include addictions, Alzheimer disease, anxiety disorders, atrial fibrillation, autism spectrum disorders, chronic pain syndromes, migraine/headaches, sleep disorders, tinnitus, traumatic brain injury, and many others as listed in the database. Relevant CPT codes include 0312T–0317T, 61885, 61886, 61888.

    Laser interstitial thermal therapy (LITT) is listed as not medically necessary for all indications other than epilepsy and intracranial lesions as depicted elsewhere in the database. Applicable unlisted and site‑specific CPT codes are provided in the database rows (for example, CPT series including 19499, 20999, 27599, 32999, 47399, 53899, 55899 are cited for LITT entries).

    Venoplasty for relapsing‑remitting multiple sclerosis is listed as investigational (not considered an established therapy) and may be denied. Relevant CPT codes listed for venoplasty include 36901–36906.

    Procedure and Billing Codes

    AbioCor® codesCPT
    33927AbioCor® Implantable Replacement Heart procedure code listed
    33928AbioCor® Implantable Replacement Heart procedure code listed
    33929AbioCor® Implantable Replacement Heart procedure code listed
    L8698AbioCor® Implantable Replacement Heart HCPCS code listed
    Scalp cooling CPT codesCPT
    0662TScalp cooling device code
    0663TScalp cooling device code
    Gene expression profiling codesCPTCovered
    0046UGene expression profiling CPT/Temp code listed
    0049UGene expression profiling CPT/Temp code listed
    0050UGene expression profiling CPT/Temp code listed
    81310NPM1 gene analysis CPT listed
    81218CEBPA gene analysis CPT listed
    81245Gene panel code listed
    81246Gene panel code listed
    Deep brain stimulation / Reclaim™ DBS codesCPT
    21499Unlisted procedure code referenced for DBS therapy entries
    61863Deep brain stimulation-related code
    61864Deep brain stimulation-related code
    61867Deep brain stimulation-related code
    61885Deep brain stimulation-related code
    61886Deep brain stimulation-related code
    61880Deep brain stimulation-related code
    61888Deep brain stimulation-related code
    95961Neurodiagnostic code referenced
    95962Neurodiagnostic code referenced
    Vagus nerve stimulation CPT codesCPT
    0312Tlisted for VNS
    0313Tlisted for VNS
    0314Tlisted for VNS
    0315Tlisted for VNS
    0316Tlisted for VNS
    0317Tlisted for VNS
    61885listed for VNS
    61886listed for VNS
    61888listed for VNS
    Venoplasty CPT codesCPT
    36901listed for venoplasty
    36902listed for venoplasty
    36903listed for venoplasty
    36904listed for venoplasty
    36905listed for venoplasty
    36906listed for venoplasty
    HUD patient population threshold
    HUD patient population threshold≤ 8,000 individuals per year
    Previous threshold (historical)Previously 4,000 individuals per year (increased to 8,000 on June 7, 2017)
    Applies toMedical devices intended to benefit patients with conditions affecting not more than 8,000 individuals in the U.S. per year

    Actions Required by Providers and Prior Authorization

    Prior Authorization

    Pre-authorization Required for AbioCor® Device

    Pre-certification is required for requests related to the AbioCor® Implantable Replacement Heart. These requests are reviewed on a case-by-case basis for all lines of business except Medicare, where coverage follows the applicable National Coverage Determination (NCD) and CMS rules for clinical studies meeting NCD criteria.

    • Pre-certification required for commercial and Medicaid LOBs; Medicare follows NCD/clinical study payment rules.
    Billing Rule

    Scalp Cooling — Not Separately Reimbursed

    Cooling caps and other scalp cooling products are considered incidental to chemotherapy administration and are not separately reimbursed. Items purchased by the member are generally considered excluded supplies when the plan excludes supplies.

    Program Background and Scope

    EmblemHealth operates a transplant program that manages members preparing for or having solid organ or bone marrow transplants. All transplant services are reviewed with the medical director assigned to the transplant case management program and are assessed for medical necessity using evidence‑based criteria; providers or members may contact the transplant program for case management and pre‑certification coordination.

    Key Definitions and Abbreviations

    HDE / HUD (Humanitarian Use Device / Humanitarian Device Exemption)
    Definition — Humanitarian Use Device (HUD)A medical device intended to benefit patients in the treatment or diagnosis of a disease or condition that affects or is manifested in not more than 8,000 individuals in the United States per year.
    Definition — Humanitarian Device Exemption (HDE)A marketing application for an HUD; an HDE is exempt from the effectiveness requirements of Sections 514 and 515 of the FD&C Act and is subject to certain profit and use restrictions.
    Regulatory noteHDE provides a pathway for marketing HUDs with modified evidentiary and profit/use provisions compared with standard PMA requirements.
    TRD (Treatment-Resistant Depression) and VNS
    Treatment-Resistant Depression (TRD) — coverage noteVagus nerve stimulation for TRD is covered for Medicare members under the National Coverage Determination (NCD) through Coverage with Evidence Development (CED).

    Transplant Candidate Eligibility and Management

    Transplant case management criteria

    Transplant program management and review

    Transplant program review: All transplant services are reviewed with the medical director assigned to the transplant case management program and are assessed for medical necessity using evidence‑based criteria; providers or members may call the transplant program for case management.

    Call 1‑800‑447‑0768

    Clinical Evaluation and Documentation Requirements

    Documentation Required

    EVALUATION REQUIREMENTS

    Requested transplant services are reviewed for medical necessity and assessed using evidence‑based criteria to support care coordination and outcomes; include sufficient clinical documentation to demonstrate necessity.

    Policy Summary
    PayerEmblemHealth
    PolicyMedical technologies and investigational transplant-related devices/services
    Policy CodePolicy N/A
    Change TypeNo material clinical or coverage changes
    Effective DateN/A
    Last ReviewApr 10, 2026
    Next Review DateN/A
    Key ActionSubmit pre-certification requests for listed devices and transplant services for case-by-case review and include supporting documentation for indications (e.g., epilepsy or Medicare TRD when applicable).
    SourceLink
    On This Page
    Coverage Determinations and Policy StatementsProcedure and Billing CodesActions Required by Providers and Prior AuthorizationProgram Background and ScopeKey Definitions and AbbreviationsTransplant Candidate Eligibility and ManagementClinical Evaluation and Documentation Requirements
    • Cooling caps/products incidental to chemotherapy — not separately reimbursed.
    • Member-purchased cooling products treated as excluded supplies when plan excludes supplies.
    Prior Authorization

    Prior Authorization and Coverage Limits for Vagus Nerve Stimulation (VNS)

    Vagus nerve stimulation (VNS) requires prior authorization. VNS is considered medically appropriate only for epilepsy per MCG guidance and for treatment‑resistant depression (TRD) under Medicare only through the NCD Coverage with Evidence Development (CED) pathway. Requests for VNS for other indications are considered investigational and may be denied.

    • Prior authorization required.
    • Covered indications: Epilepsy (per MCG #A-0424) and Medicare TRD via NCD/CED only.
    • VNS for all other indications is investigational — may be denied.
    Documentation Required

    Documentation Required for VNS Requests

    When VNS is requested, submit documentation demonstrating the member meets the applicable indication (epilepsy criteria per MCG or Medicare TRD CED enrollment/documentation). Without adequate documentation, prior authorization may be denied.

    • Provide clinical documentation supporting epilepsy diagnosis and MCG criteria OR Medicare TRD CED enrollment and study documentation.
    • Include relevant prior treatments, response history, and specialty evaluations as applicable.
    Denial Risk

    Venoplasty for Relapsing‑Remitting Multiple Sclerosis — Investigational

    Venoplasty for relapsing‑remitting multiple sclerosis (RRMS) is considered investigational and is not covered. Prior authorization may be required for venoplasty procedures generally, but venoplasty for RRMS will be denied as investigational.

    • Venoplasty for relapsing‑remitting MS — investigational; not covered.
    • Prior authorization may still be required for vascular procedures; submit documentation but expect investigational denial for RRMS indication.
    Note

    Transplant Case Management and Pre-certification

    EmblemHealth’s transplant program manages members preparing for or recovering from solid organ or bone marrow transplants. All transplant services are reviewed with the transplant program medical director as part of the pre-certification and case management process. To request transplant case management services, members and providers may call 1‑800‑447‑0768.

    • All requested transplant services are reviewed for medical necessity with the transplant program medical director.
    • Call 1-800-447-0768 to request transplant case management services.
    VNS general investigational stanceVagus nerve stimulation is considered investigational for all indications except epilepsy and TRD (Medicare CED).
    Reference — epilepsy coverageEpilepsy is an exception to the investigational stance; see MCG #A-0424 for epilepsy coverage guidance when requesting VNS.